Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - norgestimate (unii: c291hfx4dy) (norgestimate - unii:c291hfx4dy), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norgestimate 0.25 mg - sprintec® (norgestimate and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy [see clinical studies  (14)]. sprintec is contraindicated in females who are known to have or develop the following conditions: - a high risk of arterial or venous thrombotic diseases. examples include women who are known to: smoke, if over age 35 [see boxed warning and warnings and precautions (5.1)] have deep vein thrombosis or pulmonary embolism, now or in the past [see warnings and precautions (5.1)] have inherited or acquired hypercoagulopathies [see warnings and precautions (5.1)] have cerebrovascular disease [see warnings and precautions (5.1)] have coronary artery disease [see warnings and precautions (5.1)] have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see warnings and precautions (5.1)] have uncontrolled hypertension [see warnings and pr

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

proficient rx lp - norgestimate (unii: c291hfx4dy) (norgestimate - unii:c291hfx4dy), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norgestimate 0.25 mg - sprintec® (norgestimate and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy [see clinical studies(14)]. do not prescribe sprintec to women who are known to have the following conditions: there is little or no increased risk of birth defects in women who inadvertently use cocs during early pregnancy. epidemiologic studies and meta-analyses have not found an increased risk of genital or non-genital birth defects (including cardiac anomalies and limb reduction defects) following exposure to low dose cocs prior to conception or during early pregnancy. do not administer cocs to induce withdrawal bleeding as a test for pregnancy. do not use cocs during pregnancy to treat threatened or habitual abortion. advise the nursing mother to use other forms of contraception, when possible, until she has weaned her child. cocs can reduce milk production in breastfeeding mothers. this is less likely to occur once breastfeeding is well-established; however, it can occur

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - norgestimate (unii: c291hfx4dy) (norgestimate - unii:c291hfx4dy), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - sprintec® (norgestimate and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy [see clinical studies (14)]. sprintec is contraindicated in females who are known to have or develop the following conditions: there is little or no increased risk of birth defects in women who inadvertently use cocs during early pregnancy. epidemiologic studies and meta-analyses have not found an increased risk of genital or non-genital birth defects (including cardiac anomalies and limb reduction defects) following exposure to low dose cocs prior to conception or during early pregnancy. do not administer cocs to induce withdrawal bleeding as a test for pregnancy. do not use cocs during pregnancy to treat threatened or habitual abortion. advise the nursing mother to use other forms of contraception, when possible, until she has weaned her child. cocs can reduce milk production in breastfeeding mothers. this is less likely to occur once breastfeeding is well-established; howev

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastic agents - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oztec rural pty limited - zinc phosphide - bait - zinc phosphide ungrouped active 25.0 g/kg - vertebrate poison - canola | grain crop | legume crop | nut crop | pasture | safflowers | high intensity usage | rapeseed - mouse - mus spp.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

rebel distributors corp - norgestimate (unii: c291hfx4dy) (norgestimate - unii:c291hfx4dy), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norgestimate 0.25 mg - sprintec tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. method typical use† perfect use‡ (4) adapted from hatcher et al., 1998 ref. #1. in clinical trials with norgestimate and ethinyl estradiol, 1,651 subjects completed 24,272 cycles and a total of 18 pregnancies were reported. this represents an overall use-efficacy (typical user efficacy) pregnancy rate of 0.96 per 100 women-years. this rate includes patients who did not take the drug correctly. oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or th

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agprotect australasia pty ltd - chlorpyrifos; liquid hydrocarbon - emulsifiable concentrate - chlorpyrifos organophosphorus active 500.0 g/l; liquid hydrocarbon solvent other 480.0 g/l - insecticide

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

ecomed pty ltd - 30881 - protection equipment, light therapy, eyewear - a device that is worn by the user in order to cover and protect the eyes from the adverse and harmful (to the eyes) side-effect which will typically be the result of undergoing light therapy treatment. it will typically be designed as, e.g. goggles, special spectacles or a mechanical mask shaped shield. products comply with en 170.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

protect u guard, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antimicrobial hand sanitizer to help reduce bacteria on the skin recommended for repeated use

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

protect u guard, llc - benzalkonium chloride 0.1% - antimicrobial for hand sanitizing to decrease bacteria on the skin recommended for repeated use